Antihemophilic Factor (Recombinant) (Xyntha) and Ultravist Injection
Determining the interaction of Antihemophilic Factor (Recombinant) (Xyntha) and Ultravist Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
Generic Name: iopromide
Brand name: Ultravist
Synonyms: Ultravist
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant) (Xyntha)-Ultresa
- Antihemophilic Factor (Recombinant) (Xyntha)-Umeclidinium
- Antihemophilic Factor (Recombinant) (Xyntha)-Umeclidinium and vilanterol
- Antihemophilic Factor (Recombinant) (Xyntha)-Umeclidinium and vilanterol Inhalation
- Antihemophilic Factor (Recombinant) (Xyntha)-Umeclidinium Bromide
- Antihemophilic Factor (Recombinant) (Xyntha)-Umeclidinium Inhalation
- Ultravist Injection-Antihemophilic factor (recombinant) pegylated-aucl Intravenous
- Ultravist Injection-Antihemophilic factor (recombinant) porcine sequence Intravenous
- Ultravist Injection-Antihemophilic factor human
- Ultravist Injection-Antihemophilic factor Intravenous, Injection
- Ultravist Injection-Antihemophilic factor recombinant
- Ultravist Injection-Antihemophilic factor viii and von willebrand factor Intravenous